Thompson, DawnMorrice, NicolaGrant, LouiseLe Sommer, SamanthaLees, Emma KMody, NimeshWilson, Heather MDelibegovic, Mirela2017-09-292017-09-292017-10-01Thompson, D, Morrice, N, Grant, L, Le Sommer, S, Lees, E K, Mody, N, Wilson, H M & Delibegovic, M 2017, 'Pharmacological inhibition of protein tyrosine phosphatase 1B protects against atherosclerotic plaque formation in the LDLR-/- mouse model of atherosclerosis', Clinical Science, vol. 131, no. 20, pp. 2489-2501. https://doi.org/10.1042/CS201710660143-5221ORCID: /0000-0003-3301-7397/work/60546621ORCID: /0000-0003-0948-9458/work/77366287ORCID: /0000-0002-1407-7274/work/83704340ORCID: /0000-0002-2215-7952/work/147568309ORCID: /0000-0001-6193-3152/work/160847589http://hdl.handle.net/2164/9373The authors wish to thank Professor Nicholas Tonks for providing the PTP1B inhibitor trodusquemine; Linda Robertson for her help with the aorta histology; Dr Fiona Grieg for tuition into aortic dissection and Dr James Hislop for critical reading of this manuscript. We also wish to thank the British Heart Foundation (PG/14/43/30889) for supporting this research131274390engSDG 3 - Good Health and Well-beingprotein tyrosine phosphatasesmetabolic syndromesatherosclerosisR MedicineBritish Heart FoundationPG/14/43/30889Supplementary DataRJournal article10.1042/CS2017106613120